Target Price | $5,538.64 |
Price | $4,437.63 |
Potential | 24.81% |
Number of Estimates | 36 |
36 Analysts have issued a price target Booking 2026 . The average Booking target price is $5,538.64. This is 24.81% higher than the current stock price. The highest price target is $6,500.00 46.47% , the lowest is $4,330.00 2.43% . | |
A rating was issued by 41 analysts: 29 Analysts recommend Booking to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Booking stock has an average upside potential 2026 of 24.81% . Most analysts recommend the Booking stock at Purchase. |
34 Analysts have issued a sales forecast Booking 2025 . The average Booking sales estimate is $25.2b . This is 6.17% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.9b 9.13% , the lowest is $24.0b 1.13% .
This results in the following potential growth metrics:
2024 | $23.7b | 11.11% |
---|---|---|
2025 | $25.2b | 6.17% |
2026 | $27.3b | 8.39% |
2027 | $30.0b | 9.70% |
2028 | $32.4b | 8.05% |
2029 | $34.6b | 6.96% |
34 Analysts have issued an Booking EBITDA forecast 2025. The average Booking EBITDA estimate is $9.0b . This is 8.70% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.4b 13.20% , the lowest is $8.4b 1.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $8.3b | 28.21% |
---|---|---|
2025 | $9.0b | 8.19% |
2026 | $10.1b | 12.01% |
2027 | $11.5b | 13.64% |
2028 | $12.8b | 11.15% |
2029 | $14.2b | 11.25% |
2024 | 35.13% | 15.39% |
---|---|---|
2025 | 35.80% | 1.90% |
2026 | 36.99% | 3.32% |
2027 | 38.33% | 3.62% |
2028 | 39.43% | 2.87% |
2029 | 41.01% | 4.01% |
29 Booking Analysts have issued a net profit forecast 2025. The average Booking net profit estimate is $6.6b . This is 16.09% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.0b 23.01% , the lowest is $5.9b 3.62% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.7b | 47.07% |
---|---|---|
2025 | $6.6b | 16.32% |
2026 | $7.8b | 17.61% |
2027 | $9.3b | 19.37% |
2028 | $10.8b | 15.79% |
2029 | $12.4b | 15.50% |
2024 | 23.97% | 32.37% |
---|---|---|
2025 | 26.26% | 9.56% |
2026 | 28.49% | 8.49% |
2027 | 31.00% | 8.81% |
2028 | 33.23% | 7.19% |
2029 | 35.88% | 7.97% |
29 Analysts have issued a Booking forecast for earnings per share. The average Booking EPS is $200.86 . This is 16.09% higher than earnings per share in the financial year 2024. The highest EPS forecast is $212.84 23.01% , the lowest is $179.28 3.62% .
This results in the following potential growth metrics and future valuations:
2024 | $172.68 | 47.07% |
---|---|---|
2025 | $200.86 | 16.32% |
2026 | $236.23 | 17.61% |
2027 | $281.98 | 19.37% |
2028 | $326.50 | 15.79% |
2029 | $377.10 | 15.50% |
Current | 26.43 | 11.72% |
---|---|---|
2025 | 22.77 | 13.85% |
2026 | 19.36 | 14.98% |
2027 | 16.22 | 16.22% |
2028 | 14.01 | 13.63% |
2029 | 12.13 | 13.42% |
Based on analysts' sales estimates for 2025, the Booking stock is valued at an EV/Sales of 6.00 and an P/S ratio of 5.95 .
This results in the following potential growth metrics and future valuations:
Current | 6.37 | 10.59% |
---|---|---|
2025 | 6.00 | 5.85% |
2026 | 5.53 | 7.74% |
2027 | 5.04 | 8.84% |
2028 | 4.67 | 7.45% |
2029 | 4.36 | 6.51% |
Current | 6.32 | 11.92% |
---|---|---|
2025 | 5.95 | 5.81% |
2026 | 5.49 | 7.74% |
2027 | 5.01 | 8.84% |
2028 | 4.63 | 7.45% |
2029 | 4.33 | 6.51% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 17 2025 |
Cantor Fitzgerald |
Neutral
➜
Neutral
|
Unchanged | Apr 16 2025 |
JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Apr 09 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 08 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 07 2025 |
BTIG |
Neutral
➜
Buy
|
Upgrade | Apr 04 2025 |
Citizens Capital Markets |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 17 2025 |
Unchanged
Cantor Fitzgerald:
Neutral
➜
Neutral
|
Apr 16 2025 |
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Apr 09 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 08 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 07 2025 |
Upgrade
BTIG:
Neutral
➜
Buy
|
Apr 04 2025 |
Unchanged
Citizens Capital Markets:
Market Outperform
➜
Market Outperform
|
Feb 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.